• Klaria Pharma Holding AB shareholders meet Oct. 5, 2026 to vote on a rights issue of units.
• Proposed issue: up to 61,494,038 units at SEK 2.4 per unit, each unit includes four new shares and one TO1 warrant.
• Full subscription would raise about SEK 148 million before costs, with up to SEK 13 million potentially set off against existing claims.
• Meeting also asked to amend the articles to expand share capital and share-count limits to accommodate the issuance.
• Board recommends adopting the rights issue, related articles amendments, and an authorization to issue units for guarantee fees through Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 20260901:BIT:4548:0) on September 01, 2026, and is solely responsible for the information contained therein.